Notre Dame Intermédica’s $691 Million Equity Offering

Davis Polk advised Notre Dame Intermédica Participações S.A. in connection with the equity offering by Bain Capital, the controlling shareholder of Notre Dame Intermédica, of 60,000,000 common shares of Notre Dame Intermédica.

The placement agents exercised in full their greenshoe option to buy an additional 7,500,000 common shares of Notre Dame Intermédica. The aggregate proceeds of the offering amounted to approximately R$2.7 billion (approximately US$691 million), including the greenshoe option. The common shares trade on the São Paulo Stock Exchange. Common shares sold in the international offering were placed under Rule 144A and Regulation S.

Headquartered in São Paulo, Brazil, Notre Dame Intermédica is a healthcare services company focused on selling employer-sponsored health and dental plans and delivering high-quality and cost-effective services, primarily to the Brazilian middle class.

The Davis Polk corporate team included Manuel Garciadiaz (Picture), Elliot M. de Carvalho and Richard Corbett. Alon Gurfinkel and Omer Harel provided tax advice. Sijia Cai provided Investment Company Act advice.

Involved fees earner: Sijia Cai – Davis Polk & Wardwell; Richard Corbett – Davis Polk & Wardwell; Elliot de Carvalho – Davis Polk & Wardwell; Manuel Garciadiaz – Davis Polk & Wardwell; Alon Gurfinkel – Davis Polk & Wardwell; Omer Harel – Davis Polk & Wardwell;

Law Firms: Davis Polk & Wardwell;

Clients: Notre Dame Intermedica Participacoes S.A. ;

Author: Ambrogio Visconti.